Skip to main content

Table 1 Plasma parameters in rats with D-galactosamine-induced acute liver failure with or without SLV338 treatment

From: Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure

 

Con

Con+SLV

GalN

GalN+SLV

N

9

9

19

22

Aspartate aminotransferase (U/I)

266 ± 27

185 ± 11*

5802 ± 1299**

5743 ± 1217**

Alanine aminotransferase (U/I)

46 ± 7

40 ± 2

2937 ± 700***

2970 ± 592***

Gamma-glutamyl transferase (U/I)

2.0 ± 0.01

4.3 ± 2

8.4 ± 2**

9.2 ± 1**

Bilirubin (mg/dl)

0.1 ± 0.01

0.1 ± 0.01

3.2 ± 0.6**

3.7 ± 0.6***

Cholinesterase (U/l)

96 ± 14

105 ± 14

94 ± 8

87 ± 9

Total protein (g/dl)

5.0 ± 0.1

5.0 ± 0.1

4.2 ± 0.1***

4.2 ± 0.2**

Glucose (mg/dl)

159 ± 7

168 ± 7

89 ± 13***

94 ± 12**

Creatinine (mg/dl)

0.27 ± 0.02

0.40 ± 0.13

0.33 ± 0.02

0.35 ± 0.03*

Urea (mg/dl)

37 ± 3

36 ± 6

43 ± 2

44 ± 5

Sodium (mmol/l)

143 ± 0.9

142 ± 0.6

141 ± 0.4

141 ± 0.6

Lipase (U/I)

8.3 ± 0.5

9.1 ± 0.2

18.2 ± 7.6

11.0 ± 1.4

Creatine kinase (U/I)

1891 ± 169

1135 ± 90**

2687 ± 1483*

866 ± 108***

Big endothelin-1 / Endothelin-1

13.7 ± 7.0

12.5 ± 7.4

8.4 ± 3.5

18.0 ± 14

SLV338 (μg/l)

0 ± 0

703 ± 230

0 ± 0

545 ± 88

  1. Con, controls; SLV, SLV338; GalN, D-galactosamine.
  2. Data are means ± standard error of the mean.
  3. *p < 0.05, **p < 0.01, ***p < 0.001 vs. Con.